- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Paravertebral block reduced opioid intake after percutaneous nephrolithotomy
A new study published in Frontiers in Surgery shows that Paravertebral block (PVB) can effectively reduce postoperative pain in kidney surgery patients, especially percutaneous nephrolithotomy (PCNL) patients.
Vertebral blocks have been widely used in postoperative pain relief, especially in thoracic surgery. However, the efficacy and safety of PVB for pain relief after renal surgery remains uncertain. Therefore, You Zhao and his team performed this study to determine the post-operative analgesia and safety of PVB in renal surgery.
All randomized controlled trials (RCTs) until December 20, 2021 which evaluated the postoperative analgesia of PVB in renal surgery were included. A total of 16 RCTs involving 907 patients were included in the meta-analysis.
The main findings of this study are:
1. Ten studies involved patients undergoing PCNL and six involving patients undergoing other kidney surgery (nephrectomy or pyeloplasty).
2. Compared with the control group (pseudo-blocks, no blocks, or other nerve blocks), the meta-analysis showed that PVB significantly reduced postoperative opioid consumption at 24 h and decreased pain scores at other time points.
3. Within 24 h of rest and 1 h, 4 h, and 24 h of exercise after renal surgery, in addition, PVB prolongs the time to first postoperative analgesia and reduces the rate of additional postoperative analgesia art.
4. Subgroup analysis showed that the postoperative analgesia effect of PVB was greater in PCNL, and the use of bupivacaine for PVB appeared to have better efficacy.
5. In addition, there was no difference in the incidence of postoperative nausea, vomiting and pruritus between the PVB group and the control group.
In conclusion, this study indicates that PVB can effectively provide postoperative analgesia in renal surgery patients, especially in PCNL. In addition, PVB is a safe pain reliever method that does not cause dangerous complications. Limited by the quality of the included studies, the above findings still need to be verified by higher quality RCTs.
Reference:
Zhao, Y., Kan, Y., Huang, X., Wu, M., Luo, W., & Nie, J. (2022). The efficacy and safety of paravertebral block for postoperative analgesia in renal surgery: A systematic review and meta-analysis of randomized controlled trials. In Frontiers in Surgery (Vol. 9). Frontiers Media SA. https://doi.org/10.3389/fsurg.2022.865362
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751